Washington, D.C – Today, U.S. Senator Kirsten Gillibrand joined 21 Senate colleagues in calling on the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) to acknowledge the inequities in vaccine access and immediately increase access to the JYNNEOS monkeypox and smallpox vaccine to all communities across the country.
The senators wrote a letter to HHS and CDC highlighting the strain that state, local, and health officials face trying to handle the increasing number of people seeking vaccine appointments despite limited supplies. The lack of available vaccine appointments continues to fuel anxiety about a virus that is generally unfamiliar to Americans, who are urgently looking for solutions—especially those who identify with the LGBTQ+ community.
“Monkeypox is spread through direct contact and can infect anyone. Yet health care services are too often inaccessible or otherwise denied to members of at-risk communities, particularly the LGBTQ+ community,” wrote the senators. “It is critical for vaccine access to be equitable, even in high demand. Indeed, demand is so high for vaccination that appointment slots made available by public health agencies have been filled nearly instantly. Some sites have even crashed due to high traffic from our constituents.”
Since there is currently more demand than supply for the monkeypox vaccine, the senators urge the Departments to work with urgency to take the necessary steps and action to respond to this public health concern reasonably and efficiently among all communities—ensuring adequate doses and equitable distribution of the vaccine in the United States.
In addition to Senator Gillibrand (D-NY), the letter was signed by U.S. Senators Jeff Merkley (D-OR), Edward J. Markey (D-MA), Sherrod Brown (D-OH), Martin Heinrich (D-NM), Catherine Cortez Masto (D-NV), Chris Van Hollen (D-MD), Cory Booker (D-NJ), Gary Peters (D-MI), Tammy Baldwin (D-WI), Ron Wyden (D-OR), Jack Reed (D-RI), Debbie Stabenow (D-MI), Angus King (I-ME), Elizabeth Warren (D-MA), Alex Padilla (D-CA), Michael Bennet (D-CO), Jacky Rosen (D-NV), Dianne Feinstein (D-CA), John Hickenlooper (D-CO), Bernie Sanders (I-VT), and Amy Klobuchar (D-MN).
Dear Assistant Secretary O’Connell and Dr. Walenski:
We write to express concern about the increasing number of monkeypox cases in the United States and to urge the Department of Health and Human Services (HHS), including the Centers for Disease Control and Prevention (CDC), to apply an interagency approach to address this outbreak, including by increasing access to the JYNNEOS monkeypox and smallpox vaccine in the United States.
The United States has invested billions of dollars in developing, manufacturing, and stockpiling doses of the JYNNEOS vaccine as a component of a federal biosecurity program. We understand that this vaccine is the current preferred option for monkeypox vaccination, given its approval by the FDA, ease of administration, and general tolerability.
However, across the country, state and local, and health officials have reported that the limited vaccine supplies are not keeping pace with the growing number of people seeking appointments. This gap continues to fuel anxiety about a virus that is generally unfamiliar to Americans, who are urgently looking for solutions.
Monkeypox is spread through direct contact and can infect anyone. Yet health care services are often inaccessible or otherwise denied to at-risk communities, particularly the LGBTQ+ community members. Vaccine access must be equitable, even in the face of high demand. Indeed, demand is so high for vaccination that appointment slots made available by public health agencies have been filled nearly instantly. Some sites have even crashed due to high traffic from our constituents.
In light of this high demand and the communities that the outbreak has impacted in the United States to date, we implore you to work with urgency to take the necessary action to respond to this public health concern and ensure adequate doses and equitable distribution of the vaccine in the United States. We look forward to hearing back from you and continue working together to address this public health concern.
and then 